Population pharmacogenomics in Russia: insights from 6102 exomes and implications for genomic medicine
Personalized pharmacotherapy requires systematic consideration of genetic factors influencing drug efficacy and safety. The accumulation of large-scale whole-exome sequencing (WES) resources provides an opportunity to assess population frequencies of clinically significant pharmacogenetic variants; however, the a...